2019-nCoV/COVID-19 - Approaches to Viral Vaccine Development and Preventive Measures

2019-nCoV/COVID-19 - Approaches to Viral Vaccine Development and Preventive Measures

Muhammad Bilal, Roberto Parra-Saldívar, Hafiz M. N. Iqbal, Muhammad Shahzad Nazir

The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus(2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks. Among severalepidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is animportant measure to track record the overall proportion/ratio of the cumulative number of infectedpatients with the known outcome (confirmed, recovered, or deceased). Considering the ongoing fatalityrate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viralvaccine development are discussed herein. The prompt identification of high-risk entities to confront theuncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement totackle the current COVID-19 severity. Moreover, the protein visualization available at the viral surface/body can give further insight into the appropriate vaccine development.

2020

Surface proteins, Respiratory disease, safety measures, viral vaccine, 2019ncov, COVID-19, control precautions

DOI: 10.22207/JPAM.14.1.05

Journal of Pure and Applied Microbiology

Journal of Pure and Applied Microbiology

Microbiology